(-)-epigallocatechin 3-gallate decreases expression ISO FAM162A (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of FAM162A mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO FAM162A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FAM162A mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO Fam162a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM162A mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Fam162a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM162A mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Fam162a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FAM162A mRNA CTD PMID:22206623 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FAM162A mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fam162a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAM162A mRNA CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FAM162A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fam162a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FAM162A mRNA CTD PMID:21570461 and PMID:24680724 2-hydroxypropanoic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of FAM162A mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of FAM162A mRNA CTD PMID:15890375 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FAM162A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAM162A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO FAM162A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects expression ISO FAM162A (Homo sapiens) 6480464 bisphenol S affects the expression of FAM162A protein CTD PMID:31945527 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:36041667 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FAM162A mRNA CTD PMID:15890375 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of FAM162A protein CTD PMID:33236894 acrylamide decreases expression ISO FAM162A (Homo sapiens) 6480464 Acrylamide results in decreased expression of FAM162A mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FAM162A mRNA CTD PMID:15890375 and PMID:33354967 aflatoxin B1 decreases methylation ISO FAM162A (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of FAM162A gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 Tretinoin results in decreased expression of FAM162A mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FAM162A mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO FAM162A (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of FAM162A mRNA and aristolochic acid I results in decreased expression of FAM162A protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO FAM162A (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to FAM162A mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO Fam162a (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FAM162A mRNA CTD PMID:19770486 and PMID:23735875 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FAM162A mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Fam162a (Mus musculus) 6480464 bisphenol A results in decreased expression of FAM162A mRNA CTD PMID:35598803 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:36041667 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FAM162A mRNA CTD PMID:32145629 and PMID:34947998 bisphenol A increases expression ISO FAM162A (Homo sapiens) 6480464 bisphenol A results in increased expression of FAM162A protein CTD PMID:37567409 bisphenol A affects expression ISO FAM162A (Homo sapiens) 6480464 bisphenol A affects the expression of FAM162A mRNA CTD PMID:30903817 bisphenol F multiple interactions ISO FAM162A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAM162A mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:36041667 cadmium dichloride increases expression ISO FAM162A (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of FAM162A mRNA CTD PMID:25596134 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of FAM162A mRNA CTD PMID:16278290 carbamazepine affects expression ISO FAM162A (Homo sapiens) 6480464 Carbamazepine affects the expression of FAM162A mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Fam162a (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of FAM162A mRNA CTD PMID:25620056 chloroacetaldehyde affects expression ISO FAM162A (Homo sapiens) 6480464 chloroacetaldehyde affects the expression of FAM162A mRNA CTD PMID:25596134 chromium(6+) affects expression ISO Fam162a (Mus musculus) 6480464 chromium hexavalent ion affects the expression of FAM162A mRNA CTD PMID:28472532 cidofovir anhydrous decreases expression ISO FAM162A (Homo sapiens) 6480464 Cidofovir results in decreased expression of FAM162A mRNA CTD PMID:25596134 cisplatin decreases expression ISO FAM162A (Homo sapiens) 6480464 Cisplatin results in decreased expression of FAM162A mRNA CTD PMID:25596134 cisplatin increases expression ISO FAM162A (Homo sapiens) 6480464 Cisplatin results in increased expression of FAM162A mRNA CTD PMID:27392435 clodronic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 Clodronic Acid results in decreased expression of FAM162A mRNA CTD PMID:25596134 cobalt dichloride multiple interactions ISO FAM162A (Homo sapiens) 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FAM162A mRNA] CTD PMID:22202117 cobalt dichloride increases expression ISO FAM162A (Homo sapiens) 6480464 cobaltous chloride results in increased expression of FAM162A mRNA CTD PMID:22202117 cyclosporin A decreases expression ISO FAM162A (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FAM162A mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO FAM162A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAM162A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO Fam162a (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of FAM162A mRNA CTD PMID:17361019 dicrotophos decreases expression ISO FAM162A (Homo sapiens) 6480464 dicrotophos results in decreased expression of FAM162A mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of FAM162A mRNA CTD PMID:15890375 dioxygen increases expression ISO Fam162a (Mus musculus) 6480464 Oxygen deficiency results in increased expression of FAM162A mRNA CTD PMID:20880076 dioxygen increases expression ISO FAM162A (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of FAM162A mRNA CTD PMID:24236059 and PMID:25596134 disodium selenite increases expression ISO FAM162A (Homo sapiens) 6480464 Sodium Selenite results in increased expression of FAM162A mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO FAM162A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO FAM162A (Homo sapiens) 6480464 Doxorubicin affects the expression of FAM162A protein CTD PMID:29385562 doxorubicin increases expression ISO FAM162A (Homo sapiens) 6480464 Doxorubicin results in increased expression of FAM162A mRNA CTD PMID:29803840 entinostat increases expression ISO FAM162A (Homo sapiens) 6480464 entinostat results in increased expression of FAM162A mRNA CTD PMID:26272509 entinostat multiple interactions ISO FAM162A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM162A mRNA CTD PMID:27188386 epoxiconazole increases expression ISO Fam162a (Mus musculus) 6480464 epoxiconazole results in increased expression of FAM162A mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO FAM162A (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of FAM162A mRNA CTD PMID:23649840 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of FAM162A mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO Fam162a (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM162A mRNA CTD PMID:28329830 folic acid multiple interactions ISO Fam162a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM162A mRNA CTD PMID:22206623 furan decreases expression EXP 6480464 furan results in decreased expression of FAM162A mRNA CTD PMID:25539665 glyphosate decreases expression ISO FAM162A (Homo sapiens) 6480464 Glyphosate results in decreased expression of FAM162A mRNA CTD PMID:31295307 hydralazine multiple interactions ISO FAM162A (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM162A mRNA CTD PMID:17183730 ifosfamide decreases expression ISO FAM162A (Homo sapiens) 6480464 Ifosfamide results in decreased expression of FAM162A mRNA CTD PMID:25596134 indometacin multiple interactions ISO FAM162A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAM162A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM162A mRNA CTD PMID:28628672 ivermectin decreases expression ISO FAM162A (Homo sapiens) 6480464 Ivermectin results in decreased expression of FAM162A protein CTD PMID:32959892 Mesaconitine increases expression EXP 6480464 mesaconitine results in increased expression of FAM162A protein CTD PMID:37182599 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of FAM162A mRNA CTD PMID:15890375 methidathion increases expression ISO Fam162a (Mus musculus) 6480464 methidathion results in increased expression of FAM162A mRNA CTD PMID:34813904 methyl methanesulfonate decreases expression ISO FAM162A (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of FAM162A mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO FAM162A (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of FAM162A mRNA CTD PMID:23179753 more ... motexafin gadolinium increases expression ISO FAM162A (Homo sapiens) 6480464 motexafin gadolinium results in increased expression of FAM162A mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO FAM162A (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FAM162A mRNA CTD PMID:16357179 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of FAM162A mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression ISO Fam162a (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FAM162A mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of FAM162A protein CTD PMID:22776087 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FAM162A mRNA CTD PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of FAM162A mRNA CTD PMID:19716841 nickel sulfate increases expression ISO FAM162A (Homo sapiens) 6480464 nickel sulfate results in increased expression of FAM162A mRNA CTD PMID:17382205 nickel sulfate decreases expression ISO FAM162A (Homo sapiens) 6480464 nickel sulfate results in decreased expression of FAM162A mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FAM162A mRNA CTD PMID:33484710 paracetamol decreases expression ISO FAM162A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FAM162A mRNA CTD PMID:29067470 pentachlorophenol increases expression ISO Fam162a (Mus musculus) 6480464 Pentachlorophenol results in increased expression of FAM162A mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO Fam162a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM162A mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of FAM162A mRNA CTD PMID:36326898 phenobarbital decreases expression ISO FAM162A (Homo sapiens) 6480464 Phenobarbital results in decreased expression of FAM162A protein CTD PMID:35881160 phenobarbital decreases expression ISO Fam162a (Mus musculus) 6480464 Phenobarbital results in decreased expression of FAM162A protein CTD PMID:35881160 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of FAM162A mRNA CTD PMID:15890375 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FAM162A mRNA CTD PMID:15890375 potassium chromate increases expression ISO FAM162A (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of FAM162A mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO FAM162A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FAM162A mRNA CTD PMID:22079256 quercetin decreases expression ISO FAM162A (Homo sapiens) 6480464 Quercetin results in decreased expression of FAM162A mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of FAM162A mRNA CTD PMID:30851411 resveratrol multiple interactions ISO FAM162A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of FAM162A mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO FAM162A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 succimer multiple interactions ISO Fam162a (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAM162A mRNA CTD PMID:26378955 sunitinib increases expression ISO FAM162A (Homo sapiens) 6480464 Sunitinib results in increased expression of FAM162A mRNA CTD PMID:31533062 T-2 toxin increases expression ISO FAM162A (Homo sapiens) 6480464 T-2 Toxin results in increased expression of FAM162A mRNA CTD PMID:31863870 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of FAM162A mRNA CTD PMID:21515302 testosterone enanthate affects expression ISO FAM162A (Homo sapiens) 6480464 testosterone enanthate affects the expression of FAM162A mRNA CTD PMID:17440010 thimerosal decreases expression ISO FAM162A (Homo sapiens) 6480464 Thimerosal results in decreased expression of FAM162A mRNA CTD PMID:27188386 tolcapone affects binding EXP 6480464 tolcapone binds to FAM162A protein CTD PMID:19783845 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FAM162A mRNA CTD PMID:33387578 trichostatin A increases expression ISO FAM162A (Homo sapiens) 6480464 trichostatin A results in increased expression of FAM162A mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO FAM162A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM162A mRNA CTD PMID:27188386 valproic acid multiple interactions ISO FAM162A (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM162A mRNA more ... CTD PMID:17183730 and PMID:27188386 valproic acid increases expression ISO FAM162A (Homo sapiens) 6480464 Valproic Acid results in increased expression of FAM162A mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO FAM162A (Homo sapiens) 6480464 Valproic Acid affects the expression of FAM162A mRNA CTD PMID:25979313 valproic acid decreases expression ISO FAM162A (Homo sapiens) 6480464 Valproic Acid results in decreased expression of FAM162A mRNA CTD PMID:23179753 vorinostat multiple interactions ISO FAM162A (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM162A mRNA CTD PMID:27188386 zinc acetate increases expression ISO FAM162A (Homo sapiens) 6480464 Zinc Acetate results in increased expression of FAM162A mRNA CTD PMID:16357179 zinc acetate multiple interactions ISO FAM162A (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FAM162A mRNA CTD PMID:16357179 zinc atom increases expression ISO Fam162a (Mus musculus) 6480464 Zinc deficiency results in increased expression of FAM162A mRNA CTD PMID:20857495 zinc dichloride multiple interactions ISO FAM162A (Homo sapiens) 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FAM162A mRNA] CTD PMID:22202117 zinc(0) increases expression ISO Fam162a (Mus musculus) 6480464 Zinc deficiency results in increased expression of FAM162A mRNA CTD PMID:20857495